论文部分内容阅读
目的:分析米非司酮联合甲氨蝶呤治疗异位妊娠的临床效果。方法:选取我院收治的60名异位妊娠患者,随机分为观察组与对照组,对照组单纯采用甲氨蝶呤治疗,观察组采用米非司酮联合甲氨蝶呤的方式治疗,对两组患者的临床效果进行分析对比。结果:对照组中有22名患者治愈,治愈率为73.33%;观察组中有26名患者治愈,治愈率为86.67%,两组患者治愈率比较具有明显差异(P<0.05);对照组患者的平均住院时间为15.2d,不良反应发生率为53.33%;观察组平均住院时间为9.4d,不良反应发生率为36.67%。两组患者不良反应发生率及住院时间比较具有明显差异(P<0.05)。结论:米非司酮联合甲氨蝶呤治疗异位妊娠具有良好的临床效果,值得在临床应用上推广。
Objective: To analyze the clinical effect of mifepristone and methotrexate in the treatment of ectopic pregnancy. Methods: Sixty patients with ectopic pregnancy admitted to our hospital were randomly divided into observation group and control group. The control group was treated with methotrexate alone. The observation group was treated with mifepristone combined with methotrexate. The clinical effects of two groups of patients were analyzed and compared. Results: Twenty-two patients in the control group were cured, with a cure rate of 73.33%. Twenty-six patients in the observation group were cured with a cure rate of 86.67%. There was a significant difference in the cure rate between the two groups (P <0.05) The average length of hospital stay was 15.2 days. The incidence of adverse reactions was 53.33%. The average length of hospital stay in the observation group was 9.4 days. The incidence of adverse reactions was 36.67%. Two groups of patients with adverse reactions and hospitalization time had significant differences (P <0.05). Conclusion: Mifepristone combined with methotrexate has a good clinical effect in the treatment of ectopic pregnancy, which is worth to be popularized in clinical application.